Pharmaceuticals Global On demand · 24-48h

Global Blood Typing Reagent Market Strategic Research Report

Global Blood Typing Reagent Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blood Typing Reagent Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Anti-A Reagent, Anti-B Reagent, Anti-AB Reagent, Other

By Application: Medical Industry, Genetics Research, Other

Key Players: Mindray, Sysmex, Shanghai Luoda Medicine, Beckman Coulter, Bio-Rad Laboratories, DAY medical, Diagast SAS, Haemokinesis, Ortho-Clinical Diagnostics, Immucor, Diagnostic Grifols, Grifols, Aikang Biotechnology, HEMO-PHARMACEUTICAL&BIOLOGICAL, Runpu Biotechnology, Yingke Xinchuang Technology, SinaDx Biomedicals

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 129 pages

Vue d'ensemble

Scope of the Report

Blood typing reagent is a diagnostic tool specifically used to detect blood types in human blood. This type of reagent is mainly based on the principle of antigen-antibody reaction. Through the binding of specific antibodies to antigens on the surface of red blood cells, agglutination reactions are produced to determine the blood type of the blood.

Blood typing reagents usually contain a variety of antibodies, such as anti-A antibodies, anti-B antibodies, and anti-D antibodies. These antibodies can specifically recognize antigens such as A, B and Rh on the surface of red blood cells. When the antibodies in the blood typing reagent meet the red blood cell antigens in the blood of the subject, if there are antigens corresponding to the antibodies on the surface of the red blood cells, agglutination reactions will occur to form visible agglutinates. By observing the formation of agglutinates, the blood type of the blood can be determined. Blood typing reagents are widely used in clinical blood typing, blood transfusion matching, genetic disease diagnosis, paternity testing, forensic identification, etc. It is of great significance to ensure blood transfusion safety, prevent hemolytic reactions and conduct related medical research.

The development status and dynamics of the blood typing reagent market can be summarized from the following aspects:

In recent years, with the continuous advancement of medical technology and the increase in medical needs, the blood typing reagent market has continued to expand. Especially in some developing countries and regions, due to the improvement of medical infrastructure and the improvement of people's health awareness, the demand for blood typing reagents has increased significantly. According to public data, the scale of China's blood typing analyzer reagent consumables market increased by 8.2% year-on-year in 2024, showing a strong growth momentum.

Secondly, blood typing reagent products continue to integrate new technologies, such as flow cytometry and high-throughput sequencing, to improve the accuracy and efficiency of detection. The application of these technologies has promoted the development of blood typing analysis in a more accurate and faster direction. At the same time, with the development of automation and intelligent technology, the automation level of blood typing reagents is also constantly improving, reducing manual operations, reducing error rates, and improving detection efficiency.

In addition, with the improvement of medical level and the enhancement of people's health awareness, blood typing is more and more widely used in clinical diagnosis and treatment. In addition to traditional pre-transfusion blood typing, blood typing also plays an important role in genetic disease diagnosis, paternity testing, forensic identification and other fields. Especially during public health events such as the COVID-19 pandemic, blood typing, as a fast and simple means of detection, has played an important role in epidemic prevention and control and treatment, further promoting the growth of market demand.

In summary, the blood typing reagent market has broad development prospects and huge market potential.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Typing Reagent market?

What factors are driving Blood Typing Reagent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Typing Reagent market opportunities vary by end market size?

How does Blood Typing Reagent break out by Type, by Application?

This report presents a comprehensive overview of the global Blood Typing Reagent market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Anti-A Reagent
  • Anti-B Reagent
  • Anti-AB Reagent
  • Other

Segment by Application

  • Medical Industry
  • Genetics Research
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Typing Reagent market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medical Industry, Genetics Research, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Anti-A ReagentAnti-B ReagentAnti-AB ReagentOther
By Application
Medical IndustryGenetics ResearchOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Anti-A Reagent
  • 3.1.3 Anti-B Reagent
  • 3.1.4 Anti-AB Reagent
  • 3.1.5 Other
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medical Industry
  • 4.1.3 Genetics Research
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Mindray
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Sysmex
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Shanghai Luoda Medicine
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Beckman Coulter
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Bio-Rad Laboratories
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 DAY medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Diagast SAS
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Haemokinesis
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Ortho-Clinical Diagnostics
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Immucor
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Diagnostic Grifols
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Grifols
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Aikang Biotechnology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 HEMO-PHARMACEUTICAL&BIOLOGICAL
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Runpu Biotechnology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Yingke Xinchuang Technology
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 SinaDx Biomedicals
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How is Blood Typing Reagent defined?
Blood typing reagent is a diagnostic tool specifically used to detect blood types in human blood. This type of reagent is mainly based on the principle of antigen-antibody reaction. Through the binding of specific antibodies to antigens on the surface of red blood cells, agglutination reactions are produced to determine the blood type of the blood.
How is the Blood Typing Reagent market segmented by type?
By type, the market is segmented into Anti-A Reagent, Anti-B Reagent, Anti-AB Reagent and Other.
What are the key applications of Blood Typing Reagent?
Key applications covered include Medical Industry, Genetics Research and Other.
Which companies are profiled in the Blood Typing Reagent market report?
Key players profiled include Mindray, Sysmex, Shanghai Luoda Medicine, Beckman Coulter, Bio-Rad Laboratories, DAY medical, Diagast SAS and Haemokinesis, among 17 companies covered in total.
What geographies does the Blood Typing Reagent market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Blood Typing Reagent?
What factors are driving Blood Typing Reagent market growth, globally and by region?
Who should buy the Blood Typing Reagent market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medical Industry, Genetics Research and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blood Typing Reagent market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.